Koteswara Rao Yerra | Medicine and Health Sciences | Innovative Research Award

Published on by Computer Scientists Awards

Innovative Research Award

Koteswara Rao Yerra
Texas A&M University, United States

Koteswara Rao Yerra
Affiliation Texas A&M University
Country United States
Scopus ID 7201581139
Documents 90
Citations 4,645
h-index 41
Subject Area Medicine and Health Sciences
Event Computer Scientists Awards
ORCID 0000-0001-6063-904X

Koteswara Rao Yerra is a researcher affiliated with Texas A&M University whose scholarly record reflects sustained activity in medicine and health sciences. Available bibliometric information reports 90 documents, 4,645 citations, and an h-index of 41, providing a quantitative basis for assessing research visibility and influence. [1]

Abstract

The Innovative Research Award profile recognizes a research trajectory characterized by publication activity, citation visibility, and investigation of clinically relevant biomedical questions. Recent work associated with this profile examines antimicrobial photodynamic therapy, antibiotic enhancement, photosensitizer combinations, inflammatory mechanisms, and oxidative stress. These studies demonstrate an interdisciplinary orientation connecting microbiology, pharmacology, infection research, and therapeutic development.

Keywords

Antimicrobial photodynamic therapy; Klebsiella pneumoniae; antibiotics; photosensitizers; inflammation; oxidative stress; NLRP3 inflammasome; biomedical research; infection therapeutics.

Introduction

Contemporary infection research increasingly explores therapeutic strategies that can complement conventional antibiotics. Photodynamic approaches are particularly relevant because they investigate how light-activated photosensitizers may contribute to antimicrobial activity. Recent publications in this research portfolio address these questions using experimental models involving Klebsiella pneumoniae and inflammatory responses. [2]

Research Profile

The reported Scopus record comprises 90 documents and 4,645 citations, with an h-index of 41. [1] The subject classification of Medicine and Health Sciences provides a broad disciplinary context for work spanning antimicrobial strategies and host inflammatory mechanisms. The ORCID identifier 0000-0001-6063-904X provides an additional persistent researcher identifier. [5]

Research Contributions

Recent contributions include investigation of dual-photosensitizer antimicrobial photodynamic therapy combined with antibiotics against Klebsiella pneumoniae, published in Pharmaceutics in May 2026. [2] Related work evaluates methylene blue and photodithazine combinations and examines photodynamic enhancement of antibiotic effects. [3] Another study investigates cinnamaldehyde, oxidative stress, and NLRP3 inflammasome-related inflammatory responses in infected macrophages. [4]

Publications

  • Dual-Photosensitizer Antimicrobial Photodynamic Therapy (DaPDT) and Its Combination with Antibiotics — Pharmaceutics, 2026;  [2]
  • Cinnamaldehyde inhibits the NLRP3 inflammasome and inflammatory response by reducing oxidative stress in Neisseria gonorrhoeae-infected macrophages — Journal of Traditional and Complementary Medicine, 2026. [4]
  • The Combined Photosensitizers in Antimicrobial Photodynamic Therapy — International Journal of Molecular Sciences, 2025. [3]
  • Enhancing Antibiotic Effect by Photodynamic: The Case of Klebsiella pneumoniae — Antibiotics, 2025. [6]

Research Impact

The combination of substantial citation activity and a broad publication record provides measurable evidence of scholarly reach. The reported h-index of 41 indicates that a considerable portion of the indexed publication portfolio has accumulated repeated citation impact. [1] Recent publications also indicate continued engagement with antimicrobial resistance, photodynamic therapeutics, and molecular mechanisms of infection.

Award Suitability

The documented research profile is relevant to an Innovative Research Award because it combines established bibliometric activity with recent investigations addressing therapeutic challenges. The work on photodynamic treatment and antibiotic combinations is particularly aligned with innovation in biomedical research, while studies of inflammatory pathways contribute mechanistic perspectives to infectious-disease research.

Conclusion

Koteswara Rao Yerra’s documented scholarly profile presents a sustained contribution to Medicine and Health Sciences, supported by 90 documents, 4,645 citations, and an h-index of 41. Recent research extending photodynamic antimicrobial strategies and investigating inflammation-related mechanisms further demonstrates continued scientific activity in clinically relevant areas. [1]

References

  1. Elsevier. (n.d.). Scopus author details: Koteswara Rao Yerra, Author ID 7201581139. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=7201581139
  2. MDPI. (2026). Dual-Photosensitizer Antimicrobial Photodynamic Therapy (DaPDT) and Its Combination with Antibiotics: A New Investigation Modality Against Klebsiella pneumoniae. Pharmaceutics, 18(5), 587.
    https://doi.org/10.3390/pharmaceutics18050587
  3. MDPI. (2025). The Combined Photosensitizers in Antimicrobial Photodynamic Therapy: The Case of Methylene Blue and Photodithazine Against Klebsiella pneumoniae. International Journal of Molecular Sciences, 26(20), 10211.
    https://doi.org/10.3390/ijms262010211
  4. Journal of Traditional and Complementary Medicine. (2026). Cinnamaldehyde inhibits the NLRP3 inflammasome and inflammatory response by reducing oxidative stress in Neisseria gonorrhoeae-infected macrophages.
    https://doi.org/10.1016/J.JTCME.2025.06.003
  5. ORCID. (n.d.). Koteswara Rao Yerra — ORCID record.
    https://orcid.org/0000-0001-6063-904X
  6. MDPI. (2025). Enhancing Antibiotic Effect by Photodynamic: The Case of Klebsiella pneumoniae. Antibiotics.  https://doi.org/10.3390/antibiotics14080766

 

Lovyanne Vergel de Dios | Medicine and Health Sciences | Best Researcher Award

Published on by Computer Scientists Awards

Best Researcher Award

Lovyanne Vergel de Dios
UTRGV School of Medicine, United States

Lovyanne Vergel de Dios
Affiliation UTRGV School of Medicine
Country United States
Documents 1
Subject Area Medicine and Health Sciences
Event Computer Scientists Awards
ORCID 0009-0001-5672-5364

Lovyanne Vergel de Dios is a research professional affiliated with the UTRGV School of Medicine in the United States. Her scholarly activities focus on medicine and health sciences, with particular attention to advances in colorectal cancer prevention and treatment. As a Research Assistant within the UTRGV School of Medicine, she contributes to contemporary biomedical research that examines evidence-based therapeutic strategies, disease prevention, and translational medicine. Her published work reflects engagement with evolving clinical knowledge and emerging targeted therapies that continue to shape modern oncology practice.[1]

Abstract

Lovyanne Vergel de Dios has participated in biomedical research addressing colorectal cancer, one of the leading causes of cancer-related mortality worldwide. Her published review synthesizes two decades of progress in prevention strategies, aspirin-based interventions, molecular diagnostics, immunotherapy, and targeted therapeutic approaches. The work highlights the transition from conventional treatment methods toward precision medicine and personalized clinical care, providing an accessible overview of current scientific evidence for healthcare professionals and researchers.[2]

Keywords

Colorectal Cancer, Precision Medicine, Oncology, Targeted Therapy, Prevention, Biomarkers, Biomedical Research, Translational Medicine.

Introduction

Modern medical research increasingly emphasizes multidisciplinary collaboration to improve disease prevention, diagnosis, and patient outcomes. Within this environment, early-career researchers contribute by consolidating scientific evidence and supporting translational studies that bridge laboratory discoveries with clinical applications. Lovyanne Vergel de Dios represents this collaborative research approach through contributions within an academic medical institution dedicated to healthcare innovation.[3]

Research Profile

  • Research Assistant, UTRGV School of Medicine.
  • Research interests include colorectal cancer prevention and therapeutic innovation.
  • Contributor to peer-reviewed biomedical literature.
  • ORCID identifier supporting transparent scholarly communication.

Research Contributions

Her scholarly contribution centers on reviewing advances that have influenced colorectal cancer management over the past twenty years. The publication evaluates preventive interventions, screening developments, molecular biomarkers, targeted drugs, and immunotherapeutic strategies while discussing future opportunities for individualized treatment. Such evidence synthesis assists clinicians, educators, and researchers by consolidating rapidly expanding biomedical knowledge into an accessible scientific resource.[2]

Publications

  • Two Decades of Progress in the Prevention and Treatment of Colorectal Cancer: From Aspirin to Targeted Therapy. Biomedicines (2026).

Research Impact

Although currently at an early stage of publication activity, the research contributes to the dissemination of contemporary knowledge regarding colorectal cancer management. Comprehensive review articles play an important role in summarizing evidence, identifying future research directions, and supporting informed clinical decision-making across healthcare systems.[4]

Award Suitability

The Best Researcher Award recognizes scholarly dedication, scientific quality, and meaningful academic contribution. Based on publicly available scholarly information, Lovyanne Vergel de Dios demonstrates active participation in medical research, peer-reviewed publication, and institutional research engagement. These characteristics align with the objectives of recognizing researchers who contribute to scientific advancement through rigorous investigation and dissemination of evidence-based knowledge.[5]

Conclusion

Lovyanne Vergel de Dios contributes to biomedical scholarship through collaborative research focused on colorectal cancer prevention and therapeutic development. Her academic affiliation, peer-reviewed publication, and commitment to evidence synthesis illustrate a promising research trajectory within medicine and health sciences. Continued scholarly activity may further strengthen her contribution to translational medicine and patient-centered healthcare innovation.

References

  1. ORCID. (2026). Lovyanne Vergel de Dios ORCID Record.
    https://orcid.org/0009-0001-5672-5364
  2. Biomedicines. (2026). Two Decades of Progress in the Prevention and Treatment of Colorectal Cancer: From Aspirin to Targeted Therapy.
    https://doi.org/10.3390/biomedicines14071472
  3. The University of Texas Rio Grande Valley. School of Medicine.
  4. DOI Foundation. Digital Object Identifier System.
  5. Computer Scientists Awards. Best Researcher Award Information.
    https://computerscientists.net/